COMMUNIQUÉ DE PRESSE publié le 08/08/2024 à 07:00, il y a 2 années HAMBORNER REIT AG: Stable business performance in the first half of the year in line with planning - confirmation of full-year forecast for 2024 HAMBORNER REIT AG reports stable business performance in the first half of 2024, with increased rental income and FFO. Full-year forecast for 2024 confirmed Business Performance Rental Income HAMBORNER REIT AG FFO Full-year Forecast
COMMUNIQUÉ DE PRESSE publié le 08/08/2024 à 07:00, il y a 2 années KNAUS TABBERT - Strong result in the first half of 2024, Knaus Tabbert brands remain market leader for motorhomes Knaus Tabbert AG reports strong first half 2024 results with revenue of EUR 699.4 million and brands leading in motorhomes. Updated forecast confirmed Forecast Knaus Tabbert AG Leisure Vehicles Motorhomes First Half Results
COMMUNIQUÉ DE PRESSE publié le 08/08/2024 à 07:00, il y a 2 années HIAG Capital Market Day 2024 HIAG Immobilien Holding AG invites associates to Capital Market Day 2024, showcasing diverse property portfolio with site tours and project insights Property Portfolio HIAG Immobilien Capital Market Day 2024 Site Tours Project Insights
COMMUNIQUÉ DE PRESSE publié le 08/08/2024 à 07:00, il y a 2 années Communiqué : Le traitement d’induction par Sarclisa a démontré une amélioration significative de la survie sans progression chez les patients atteints d’un myélome multiple nouvellement diagnostiqué et éligibles à une transplantation Le traitement d’induction par Sarclisa montre une amélioration significative de la survie sans progression chez les patients atteints de myélome multiple nouvellement diagnostiqués et éligibles à une transplantation Myélome Multiple Sarclisa Survie Sans Progression Traitement D'induction GMMG-HD7
COMMUNIQUÉ DE PRESSE publié le 08/08/2024 à 07:00, il y a 2 années Press Release: Sarclisa induction treatment demonstrated significantly improved progression-free survival in patients with newly diagnosed multiple myeloma eligible for transplant New data shows Sarclisa induction therapy improves progression-free survival in transplant-eligible newly diagnosed multiple myeloma patients. GMMG-HD7 study results are promising for Sarclisa as part of frontline treatment Multiple Myeloma Sarclisa Progression-free Survival GMMG-HD7 Study Frontline Treatment
COMMUNIQUÉ DE PRESSE publié le 08/08/2024 à 06:59, il y a 2 années grenke increases Group earnings and improves cost-income ratio in the first half of 2024 grenke AG increases Group earnings by 11.3% and improves cost-income ratio to 57.1% in the first half of 2024. The company reconfirms its 2024 forecast, showcases refinancing strength, and reports positive financial figures Financial Report Profitability GRENKE AG Cost-income Ratio Group Earnings
COMMUNIQUÉ DE PRESSE publié le 08/08/2024 à 06:59, il y a 2 années Aareal Bank fully on course in the first half of the year Aareal Bank's first half-year results show a 31% rise in operating profit to €181 million. Net interest income and capital ratios remain strong. CEO Dr Christian Ricken praises the bank's robust performance Operating Profit Aareal Bank Net Interest Income First Half-year Results CEO Dr Christian Ricken
COMMUNIQUÉ DE PRESSE publié le 08/08/2024 à 06:59, il y a 2 années Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Maintains Profitable Growth Knorr-Bremse AG maintains profitable growth with impressive 2024 first half results and increased full-year guidance. Continuity on the Executive Board confirmed. Details on BOOST 2026 strategy and divisional performances Executive Board Profitable Growth Full-year Guidance Knorr-Bremse AG BOOST 2026
COMMUNIQUÉ DE PRESSE publié le 08/08/2024 à 06:59, il y a 2 années Allianz SE: Allianz achieves record profits in first half 2024 Allianz SE achieves record profits in the first half of 2024, driven by strong performance in all business segments. Operating profit reaches 7.9 billion euros, with core net income of 5.0 billion euros. Solvency II ratio at 206 percent Operating Profit Allianz SE Record Profits Solvency II Ratio First Half 2024
COMMUNIQUÉ DE PRESSE publié le 08/08/2024 à 06:58, il y a 2 années SMA Group reports a solid first half of 2024 in a challenging market SMA Group reports a solid first half of 2024 with sales at €759.3 million, EBITDA of €80.6 million, and confirmed 2024 guidance. Details on market challenges and segment performances Sales EBITDA Market Challenges SMA Group Segment Performances
Publié le 07/09/2026 à 18:05, il y a 19 minutes AXA: Information relating to the number of voting rights and shares making up the share capital on 31/08/2026
Publié le 07/09/2026 à 18:05, il y a 19 minutes AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/08/2026
Publié le 05/09/2026 à 04:05, il y a 2 jours 14 heures Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Publié le 04/09/2026 à 23:30, il y a 2 jours 18 heures FutureGen Industries Announces Shares for Debt Settlement
Publié le 04/09/2026 à 23:00, il y a 2 jours 19 heures Golden Minerals Announces Management Change and Argentine Project Update
Publié le 04/09/2026 à 22:30, il y a 2 jours 19 heures Panther Minerals Closes Brokered Private Placement of $3,000,000
Publié le 04/09/2026 à 14:30, il y a 3 jours 3 heures Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
Publié le 07/09/2026 à 18:00, il y a 24 minutes E-PANGO: e-Pango organise un webinaire avec ses actionnaires
Publié le 07/09/2026 à 17:45, il y a 39 minutes VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Publié le 07/09/2026 à 17:11, il y a 1 heure 13 minutes EQS-Adhoc: fox e-mobility AG: Unqualified Audit Opinion for 2024 Financial Statements / Preliminary Figures for 2025 and First Half 2026
Publié le 07/09/2026 à 16:10, il y a 2 heures 13 minutes Redcare Pharmacy welcomes further progress on PoPP: New preliminary specification lays the groundwork for Health ID in remote care.
Publié le 07/09/2026 à 16:02, il y a 2 heures 22 minutes Original-Research: LAIQON AG (von First Berlin Equity Research GmbH): Buy